Quote Level 2 Charts News Trades Historical Financials Message Board
SureTrader SureTrader

Taxus Cardium Pharmaceuticals (CRXM)

$ 0.175 ▼-0.004 (-2.23%)
Volume: 7,420
Add CRXM To StreamerAdd CRXM To Streamer
Add CRXM To My StocksAdd CRXM To My Stocks
Add CRXM Price AlertAdd CRXM Price Alert
Bid Ask Last Traded Open Prev Close
0.10 0.44 8:20:20 PM EST 0.172 0.179
Day's Range 52-Wk Range Avg Volume EPS P/E
0.1002 - 0.175 0.06 - 0.40 14,299 N/A N/A
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
2.30M 12.78M N/A N/A N/A
Short Interest Short % of Out Insider B/S Inst % Owned Exchange
18,864 0.15 % N/A N/A USOTC
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 0.0753 $ 0.1251 $ 0.1501 $ 0.1999 $ 0.2249
Link to Taxus Cardium Pharmaceuticals Stock Price

Taxus Cardium Pharmaceuticals Group, Inc. (PL) Company Description


Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations. Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform. The Company's lead commercial product Excellagen(R) topical gel for wound care management, has recently received FDA clearance for marketing and sale in the United States. Cardium's lead clinical development product candidate Generx(R) is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.

CRXM Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y


CRXM vs ETF alternatives
ETFsToday3mths1YrYTD
CRXM-2.23%-7.89%-41.67%-49.28%
IJR0.27%5.24%6.18%13.75%
EES0.23%4.05%4.06%12.44%
SCHA-0.04%4.71%0.59%10.90%
VIOO0.22%5.62%6.28%14.55%
VB-0.22%4.69%1.28%11.06%
DWAS0.32%5.11%-10.53%3.37%
SAA0.00%9.03%8.16%25.87%
Most Recent CRXM Videos
No CRXM Videos…



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.